Postpartum Hemorrhage clinical trials

Explore recruiting postpartum hemorrhage clinical trials.

Recruiting postpartum hemorrhage studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Postpartum Hemorrhage trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blind placebo controlled trial. TRAAPrevia

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aspirin for the Prevention of Preeclampsia and Pregnancy outcomes in nulliparous women after Assisted Reproductive Technology. APPART trial

France

Phase III and phase IV (Integrated) EU CTIS Study details

Luteal phase support following letrozole treatment in women undergoing intrauterine insemination: a multicenter randomized trial

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Frozen-thawed embryo transfer in a natural versus artificial cycle: a randomized clinical trial.

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial

Iceland, Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Low molecular weight heparin in the treatment of early fetal growth restriction – a Randomized Controlled Trial

Portugal

Therapeutic use (Phase IV) EU CTIS Study details

Postpartum Hemorrhage trials by city

Postpartum Hemorrhage in Toronto Postpartum Hemorrhage in Vancouver Postpartum Hemorrhage in Montreal Postpartum Hemorrhage in Calgary Postpartum Hemorrhage in Edmonton Postpartum Hemorrhage in Ottawa Postpartum Hemorrhage in Winnipeg Postpartum Hemorrhage in Quebec City Postpartum Hemorrhage in Hamilton Postpartum Hemorrhage in Kitchener Postpartum Hemorrhage in London Postpartum Hemorrhage in Halifax Postpartum Hemorrhage in New York Postpartum Hemorrhage in Los Angeles Postpartum Hemorrhage in Chicago Postpartum Hemorrhage in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease